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Abstract For the Pan American Health Organization
(PAHO), the care of patients with chronic diseases currently
experiences fragmentation in attention, generating poor per-
formance of health services. Thus, comprehensive health care
strategies arise to mitigate these problems; one of them are
Centers of Excellence (CoEs), which aim to obtain high qual-
ity results in health from the adequate and minimum use of
resources. The objective of this study was to describe the
history and current context of the CoE in comprehensive care
in patients with rheumatoid arthritis (RA). A systematic search
of the literature terms (MeSH) was performed. The bases used
were PubMed, Ebsco Host, Lilacs, Science Direct, Ovid, and
Google (gray literature). The source of the information was
evaluated to determine its quality. International standards
focus the CoEs starting from comprehensive management of
patients with RA and patient volume, continuous improve-
ment, and quality of health care, constituting an interdisciplin-
ary team. The REAL-PANLAR group suggested that the in-
clusion of the strategy BTreat to Target^, and patient education
improves patient conditions and understanding of the disease.
RA is a prevalent and costly disease. The creation of compre-
hensive care centers of the CoE type is an initiative that im-
proves the prognosis of RA. This document aims to encourage
rheumatologists and scientific societies to structure CoE in an
interdisciplinary endeavor.
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Introduction
For the Pan American Health Organization (PAHO), the care
of patients with chronic diseases currently experiences frag-
mentation in comprehensive care, generating poor perfor-
mance of health services, and demonstrating difficulties of
access, diagnosis, treatment, and management of the patient
environment. Additionally, it faces a deficit of technical qual-
ity due to the irrational and inefficient use of resources, adding
to the negative perception by the users [1]. This scenario is the
result of a lack of administrative organization, where the eco-
nomic aspect has been prioritized, leaving the patient in the
background. Because of this, strategies to mitigate these prob-
lems that are articulated with elements of public health arise.
One of them is creating highly specialized comprehensive care
centers which aim to concentrate the population and centralize
the management of the disease, which has led to the creation
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obtain high quality results from the appropriate and minimal
use of resources as part of what Castaño suggested starting
from three fundamental pillars: (1) the volume/demand of the
specific condition or diagnosis, (2) the culture of continuous
improvement, and (3) the quality of the health care profession-
al [2]. This initiative began in the 1990s, due to the shortcom-
ings of health systems, where the monopolization by the sup-
plier does not meet demand, taking into account the geograph-
ical distribution of patients (rural and urban areas and the
difficulty of access) and coverage throughout the country. In
addition to this problem, there is the lack of availability of
health professionals to manage chronic diseases [3] that im-
pact the patients’ psychological, social, and economic aspects.
The clinical features of rheumatoid arthritis (RA) and its epi-
demiological behavior justify the need for a management that
involves all of the patient’s spheres and their context. It has
been estimated that the prevalence of RA in Latin America is
between 0.4 and 1.6 %. A study done in Mexico shows that
the prevalence in this country is of 1.6 % with a CI of 95 %
(between 1.4 and 1.8 %) and that this disease is more frequent
in women with a ratio of 3–1 [4, 5]. This condition is associ-
ated with emotional disorders due to chronic pain, permanent
functional impairment, anatomical deformities, and loss of
independence within their environment [6].
The World Health Organization (WHO) suggests that for
the proper care of RA, there should be a rheumatologist per
100,000 people, i.e., that about 5000 specialists would be
needed for Latin America; however, there are 19 rheumatolo-
gy societies grouping about 2000 members, showing a prob-
lem in diagnosis and treatment for lack of human resources.
Additionally, the quality indicators that are evaluated in dif-
ferent models of care are not met fully due to the lack of an
organizational structure that allows for a comprehensive ap-
proach to patient management [1, 7]. Another key element in
the problem identified is the variation in behavior for the treat-
ment of RA, because despite the existence of evidence-based
clinical practice guidelines there is no unifying handling com-
pliance, directly affecting the clinical course of the disease [7,
8]. This series of obstacles faced by patients, health profes-
sionals, and health services make the argument for structuring
organizations capable of focusing on the patients and their
condition in order to improve the quality of service delivery
as the structuring of CoEs proposes. Therefore, this paper
aims to describe the history and current context of Centers
of Excellence in comprehensive care in patients with rheuma-
toid arthritis (RA).
Methods
A systematic literature search with the following keywords
was performed: rheumatology, quality, efficiency (MeSH),
Center of Excellence, comprehensive care, and learning curve,
which were combined using Boolean operators AND, OR,
and NOT. Search was not limited by year or by language.
The databases searched were PubMed, Ebsco Host, Lilacs,
Science Direct, and Ovid. Additionally, gray literature was
considered using the metasearch engine Google Scholar. The
source of the information was evaluated to determine its qual-
ity and affiliations of the authors (Fig. 1).
Results
Approximation and route for diagnosing of the RA patient
The success of the diagnosis of RA begins with clinical sus-
picion of the disease in primary care levels, where the identi-
fication of patients with symptoms suggestive of RA should
be integrated special programs for disease management. In a
systematic review, Chan found the path that patients usually
follow and the obstacles they face, added to those previously
described, until reaching specialized treatment, while at the
same time identified the solutions that could help improve
the quality of patient care. The same study reported the aver-
age time for accessing health services: first moment, the user
consults at the first level (4–12 weeks); second moment, the
patient is referred to a rheumatologist (2–3 months); and third
moment, the patient receives treatment from his or her insurer
(2–3 weeks) [8]. On the other hand, Ruiz says that the avail-
ability of nurses in a leading RA attention center must be
organized as follows: one nurse for every three consulting
rooms, an auxiliary nurse for every two consulting rooms,
and an administrative for every four doctors. Ruiz also states
that a health system should have three beds for RA patients per
100,000 inhabitants considering the statistics described. These
parameters are critical to improving health care quality and
reduce access times [9, 10].
This procedure is affected by factors inherent in the system
and the patient’s difficulties, due to the lack of information or
disability that prevents management for the monitoring of the
disease (Fig. 2) [11].
Such proposals are the gateway to the formation of inter-
disciplinary teams for the comprehensive management of AR,
allowing the structuring of centers of excellence.
Centers of excellence
According to the above, the CoEs are a sustainable com-
petitive strategy, both locally and internationally, which is
understood as a health program that fully complies with
indicators of effectiveness and safety at competitive costs
in the marketplace. According to Castaño, this theory is
based on the learning curve (acquisition of cognitive and
manual skills) of health care [2], which leads to the three
pillars of structuring a CoE (Fig. 3).
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Rheumatoid arthritis and pillars of excellence
BThe volume of patients with a specific condition or
entity^ includes the first pillar, and where the target
population are patients with RA. This pillar aims to
ensure a considerable number of patients, allowing the
CoE group to concentrate on RA pathology and feed
the experience curve for health professionals [12] and
ensure comprehensive care. For the organization of the
centers, it is important to note that different health sys-
tems in each country should collaborate with patient
mobility setting aside self-interest of the provider and
opening the possibility that the focus is on the patient.
Once the logistics to collect and cite patients in a single
center are obtained, it must define a program of contin-
uous improvement, quality assurance processes, and pro-
cedures in comprehensive care, adding knowledge man-
agement, which involves the research and technological
innovation, supported by a group of experts which im-
proves clinical and administrative decision-making.
Castaño explains this pillar, with the PDVA acronym,
where each letter stands for Plan-Do-Verify-Act [2].
The second pillar refers to the concept of Bcontinuous
improvement^, which is based on all activities that
Fig. 1 Source of the information
Fig. 2 The health system
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organizations or companies constantly perform to improve
quality processes [3] with a competitive approach and improv-
ing the patient’s or user’s perceptions. In this vein, the respon-
sibility of the scientific societies is not limited to the organi-
zation of conferences and meetings, but are also indirectly
responsible for patient care, which must conform to interna-
tional and local lineaments, which in often are the result of
rigorous and systematic processes such as the evidence-based
guidelines for clinical practice.
For this reason, the Pan American League of Associations
for Rheumatology (PANLAR), currently leads a number of
initiatives to establish centers to fully treat patients with RA,
for which it assigned the BReal–PANLAR project for the im-
plementation and accreditation of centers of excellence in
rheumatoid arthritis throughout Latin America^, project to a
group of Latin American rheumatologists who after a thor-
ough bibliographic research, and a Delphi type expert consen-
sus, suggests the following indicators for a center of excel-
lence in RA [7, 13, 14]:
1. Structure indicators: Evaluate the institutional capacity to
deliver the expected results, adequate infrastructure, suit-
able personnel including rheumatologists and other pro-
fessionals to ensure comprehensive attention, and the ex-
istence of complementary resources (e.g., clinical labora-
tory and imaging).
2. Process indicators: Adherence to management recom-
mendations based on treatment strategy by objectives
Treat to Target (T2T), in addition to including educational
processes directed to the patient by the interdisciplinary
team.
3. Outcome indicators: The achievement of the objectives
proposed along the care or comprehensive patient
must be evaluated. The progression of the disease,
functional disability, and the achievement of remission
goals must be quantified using clinimetric scales such
as joint counts, DAS28, HAQ, CDAI, and ACR
among others.
Furthermore, a conceptually comprehensive quality care
means taking into account a number of recommendations that
enable better care [7, 13, 14]:
& Committees to define the integrity of treatment, where
issues such as disease activity, quality of life, compliance,
and adherence to treatment are involved.
& Unification of handling and socialization of clinical prac-
tice guidelines according to each country.
& Minimum standard evaluation based on the T2T strategy.
& Defining the processes and procedures for patients to ac-
cess groups of experts in RA
& Increasing the patients’ involvement in disease manage-
ment with effective pedagogical activities.
& Constitution of information systems for multi-centric stud-
ies nationally and internationally.
& Negotiating with the different health systems the imple-
mentation of strategies to reorganize the distribution of
patients to different groups or specific centers in attention
of RA [7].
Compliance with these parameters strengthens the compet-
itiveness of the centers specialized in RA management,
allowing for offering the best service, which must constantly
be compared with similar centers. According to Porter, com-
petition in health care has become a noncompetitive monop-
oly where providers divide the market amongst them, or in the
worst cases, are concentrated in a few. This causes costs to be
transferred, but not reduced. Currently, the costs are shifted,
from supplier to hospital, hospital to doctor, and doctor to
patient, without generating a net cost concentrated by pathol-
ogy or entity, dispersing the impact on the system and encour-
aging the cheaper and less effective treatments. In an adequate
competition, permanent improvements in patient care become
efficient resources allocated by insurers, providing better qual-
ity of service and offering the use of new technologies such as
diagnostic tests and modern drugs among others, bringing
about the possibility of expansion of the local market and
the option of selling models of care in different regions [3].
This scenario is reflected in the management of diseases that
are considered high cost and where AR is included, as the
processes to access a comprehensive treatment vary depend-
ing on the provider or insurer.
The third pillar is the quality of health care,where efforts are
focused on academic and human quality of the members of the
interdisciplinary team to provide comprehensive management.
The CoE should ensure that each person that is part of the path
and comes into contact with patients with RA is specifically
trained for this entity and know the context in which the pro-
cesses are developed to avoid different obstacles. For this pur-
pose, one of the tools used is the ongoing assessment and co-
assessment to ensure competitiveness within the group, im-
proving academics and the workplace organizational climate.
Fig. 3 Learning curve for healthcare
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Additionally, meetings or scientific committees headed by the
leader rheumatologist should exalt capabilities and empower
their employees to strengthen the learning curve and keep a
cohesive team with permanent bargaining power. These orga-
nizational skills become important in the CoE, since they allow
socializing aspects related to evidence-based medicine for joint
decision making in all areas affecting the patient. On the other
hand, they aim to reduce the rotation of professionals who have
gained experience, improving human resource management,
and directly impacting the care process, with high focus of
humanism and high scientific quality [2].
Long-term consolidation of these three pillars guarantees that
the learning curve increases, hence, the expertise of the interdis-
ciplinary team provides the best care for patients with RA. In
this context, clinical groups should be led by rheumatologists,
and these must be accompanied by professionals in nursing,
physical therapy, psychology, or psychiatry, as well as pharma-
ceutical chemists, social workers, and among others. Addition-
ally, CoEsmust have administrative support that enables tomeet
the indicators of organizational management, ensuring the ad-
ministrative and logistical operation of the center (Fig. 2).
Additionally, the REAL-PANLAR group suggests a clinical
overview of the characteristics of a Center of Excellence in
comprehensive care in RAwhich supplements aspects of clin-
ical management aforementioned by Castaño. This manage-
ment must start from a medical analysis and clinical diagnosis,
which helped by clinimetric results (DAS28, ACR, HAQ,
CDAI, and SDAI), and diagnostic tests such as the clinical
laboratory (rheumatoid factor, ACPA’s, and other labs) and
conventional radiology are indispensable for the differential
diagnosis, treatment, and monitoring of the patient. Once the
therapy line is defined, it is vital that the patient be included in
the strategy for BTreat to Target^, which seeks that the patient
go towards to a proper control of RA considering the therapeu-
tic goal clearly defined by the rheumatologist and his interdis-
ciplinary team, involving, of course, the patient, for his active
participation in this process allows for meeting the clinical ob-
jectives in place [7, 15, 16]. Associated with this, standardiza-
tion of medical records management brings about as a result of
the organization of information for the health professionals so
that they can gain access to information regarding the different
interventions performed. Parallel and from the start of treat-
ment, patient education plays a fundamental role in manage-
ment, because if the patient improves the conditions of their
care, there will be a better adherence to treatment, thus improv-
ing its result. This strategy should be offered by various means
(virtually, courses, and classroom lectures), after assessing pa-
tient schooling and family context for learning support [7].
Comprehensive attention
Consistent with the above, a proposal for structuring a model
of comprehensive care for RA is presented. This model should
have as its main goal reducing the functional limitations and
those related to the patient’s psychosocial performance,
aiming to improve the quality of life. To meet this objective,
we suggest (Fig. 4) [7, 17, 18]:
& Designing an educational program to involve the patient
and to be a part of the attention process.
& Focusing efforts on the prevention of complications or
avoiding disability, reducing handling costs.
& Periodic interdisciplinary control to determine disease
progression and its impact.
& Evaluation of compliance to pharmacologic and non-
pharmacologic treatment.
& Implementation of risk management strategies that must
be cost effective for the fulfillment of therapeutic goals.
These proposals are integrated into shared responsibility,
avoiding that decisions be vested in a single subject regardless
of the concept of different professionals who are involved
with the patient [19].
This model articulates and summarizes what was described
by Li regarding the team that should take care of the patient
with RA and mentioned by Castaño where the CoE is
concerned.
The establishment of CoEs in RA is not limited to the admin-
istrative, but has to dowith integrated health care models and the
clinical ability to define and clarify the route of RAmanagement
taking into account the potential obstacles characteristic to each
region.
Moreover, as already mentioned above, the CoE in its
philosophy of continuous improvement must be assessed
and accredited cyclically; currently, in several countries,
there are accreditation bodies or health certifications for
certain pathologies or all of them. In Colombia, for exam-
ple, for 20 years, the Organization for Excellence in
Health (Organización para la Excelencia en Salud–OES)
is responsible for evaluating the Centers of Excellence in
health. This organization aims to Bpromote and lead the
improvement of health care quality through management
of sector institutions^ from the research, innovation, and
intervention, ensuring compliance minimum standards and
continuity according to the indicators established in the
evaluation manual [20, 21].
This manual bases the assessment of CoEs on three items:
1. Standards
2. Evaluators
3. Evaluation and qualification process
The standards are based on the philosophy of contin-
uous improvement, user-centric management, patient
safety, production, and sale of services and competitive-
ness, within which performance measurement, health
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equipment, and processes of comprehensive patient care
are defined. These standards must be recognized by ref-
erent experts in RA, health management, and similar RA
centers of excellence, where the following parameters
[17] will be considered:
& Attention based on clinical practice guidelines and expe-
rienced professionals.
& Perception of the patients and their family of the attention.
& Knowledge management should be permanent, generating
research productivity, from an information system or
powered by collection of patient data, ensuring confiden-
tiality, and acting in accordance with good clinical practice
standards.
& Suitable physical structure and human resource in the
comprehensive care of RA.
With respect to the evaluators, they must be (1) medical
professionals in rheumatology with research experience and
recognition in the clinical setting and (2) health professionals
expert in management and quality assessment.
Finally, the process of evaluation and assessment is based
on the application of a series of checklists that assess: Verifi-
cation methods in which methodology for compliance indica-
tors and objectives defined for the CoE are included in the
framework of a Manual of Evaluation [21]. Additionally, doc-
uments of constitution, minutes of committees, appointments
of professional and support staff, evidence of compliance pro-
cesses, and procedures in the field are reviewed. One of the
medium-term proposals by the REAL-PANLAR project for
the establishment of centers of excellence in RA in Latin
America precisely seeks to raise the creation of a center of
accreditation or certification attached to Panlar and to provide
not only evaluation processes for the applicant centers but also
advice on continuous improvement in the quality of care in
RA [7].
As a result of the revision, we can define three factors that
articulate comprehensive attention of RA, namely: the deter-
mination of a clinical route, the structure of an excellence
center, and its role in patient management.
This route begins from the identification of symptoms by
the patients and their consultation at the primary level, follow-
ed by referral to the rheumatologist and assessment, in order to
confirm the diagnost ic suspicion. This act ion is
complemented by the interdisciplinary evaluation, which fo-
cuses on the customization of the treatment using clinical
strategies and follow-up such as T2T, which involves the en-
vironment with the management, whose main goal is the pa-
tient’s global quality of life. Additionally, elements of the cen-
ter of excellence are integrated to guarantee the clinical route’s
quality and its timely attention by specialized professionals.
These processes are evaluated continuously assuring the com-
pliance with the indicators that give as a result the success of
the medical management.
Fig. 4 Comprehensive care for RA
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Conclusions
RA is a prevalent and high cost disease, which needs compre-
hensive care by an interdisciplinary group of professionals in
high-quality health, in order to provide the best care,
impacting the prognosis, and involving the patient in the treat-
ment process.
The creation of comprehensive care centers such as CoEs
or similar is an initiative to continually improve processes of
care and management of RA, starting from structuring scenar-
ios that guarantee the concentration of RA patients, a team of
professionals health that has expertise and humanism, leaders
in innovation and research, supported by pedagogical strate-
gies focused on the patient and under clinical monitoring of
the T2T type.
This paper aims to motivate rheumatologists and scientific
societies of different regions in an interdisciplinary effort to
structure from centers of integrated management for RA, Cen-
ters of Excellence in RA, considering the volume of patients
with this entity, the limited availability of specialized health
professionals in this area and obstacles in the comprehensive
care of patients.
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